@article{98620,
  keywords = {Leprosy, anti-M. Leprae, IgM antibodies},
  author = {Lema T and Bobosha K and Kasang C and van Hooij A and Mengiste A and Geluk A and Aseffa  and Woldeamanuel Y},
  title = {Increased anti-M. Leprae PGL-I igm levels in a child who developed leprosy},
  abstract = {<p>As part of a study that aimed at reaching those at risk of developing leprosy through screening of household contacts, a child aged 7 was included as contact of a multibacillary leprosy patient. This study was conducted in Kokosa, hot spot area in Oromia Region, Ethiopia. Compared to other contacts, this child showed increased levels of anti-M. leprae Phenolic glycolipid-I (PGL-I) IgM antibodies as assessed by up-converting lateral flow assay (UCP -LFA) at initial and second-time screening and developed leprosy three years later. Therefore, the anti-PGL-I IgM UCP-LFA can serve as an additional diagnostic field tool in leprosy control programs.</p>
},
  year = {2023},
  journal = {Ethiopian Medical Journal},
  volume = {60},
  pages = {293-295},
  issn = {2415-2420},
  url = {https://www.ajol.info/index.php/emj/article/view/252306/238370},
  language = {Eng},
}